Excitatory amino acids in epilepsy and potential novel therapies.
about
Molecular targets for antiepileptic drug developmentPlasticity of Hippocampal Excitatory-Inhibitory Balance: Missing the Synaptic Control in the Epileptic BrainThe pharmacology and therapeutic potential of (-)-huperzine A.Glutamate in neurologic diseasesUpregulation of glutamate receptors in rat cerebral cortex with neuronal migration disordersRemacemide: current status and clinical applications.The relevance of individual genetic background and its role in animal models of epilepsyTemporal lobe epileptogenesis and epilepsy in the developing brain: bridging the gap between the laboratory and the clinic. Progression, but in what direction?Therapeutic potential of metabotropic glutamate receptor modulators.In vivo contributions of BH3-only proteins to neuronal death following seizures, ischemia, and traumatic brain injury.Guidelines for the evaluation and management of status epilepticus.Antiepileptic drug discovery: lessons from the past and future challenges.Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development.Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfalls.Effects of linalool on [(3)H]MK801 and [(3)H] muscimol binding in mouse cortical membranes.Prolonged NMDA-mediated responses, altered ifenprodil sensitivity, and epileptiform-like events in the malformed hippocampus of methylazoxymethanol exposed rats.Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis.Convulsant action of D,L-homocysteic acid and its stereoisomers in immature rats.Epileptiform propagation patterns mediated by NMDA and non-NMDA receptors in rat neocortex.
P2860
Q24683346-4CB39A69-C574-4900-94B1-62F77C010C0FQ26752412-BF5C2AC4-3D5B-4C22-8800-6E760F8A37CCQ27691305-B722D524-6358-42ED-9272-845A68C319D5Q28259105-F017D014-5C59-4D1C-AB37-E4E48C4D8901Q33631592-24E0C4FC-9B26-40C2-97E6-518BDA13F86AQ34074824-0A9F6E26-5B00-464C-A494-DACFC0C276CEQ35549275-29863E98-DB1E-4846-8BF6-E7C5BFB7E405Q35594574-AFBE54E6-1D17-4987-89D0-18BFD2DEE51FQ35778704-C75E46C4-F4DE-4EA4-A96B-993F4F092D7AQ37848658-095FA6DC-4E68-4E10-BE62-B2A41A2D7CD3Q38004984-4B075945-5544-4F96-9647-1D2B1396A19AQ40379424-732948A3-9414-4D30-ACA6-83C689A7221FQ40748938-AF41CCB5-0937-4ECF-A3C7-6CDE5452B056Q41598543-76F7F7EE-F968-4DF1-B3EF-A6D537456376Q43708817-A7E44D34-29F6-4594-9177-81D98A0C56F7Q45983039-63FBC821-71EB-4EB4-BE2F-0FDA4D0BF270Q48296991-D096D679-7608-4CBC-B192-E38EA648E92DQ48661494-561E578D-A334-4AD1-B549-82E3B85E2339Q52537036-866F8434-EADD-46A4-8BEC-CFE25E58BC9E
P2860
Excitatory amino acids in epilepsy and potential novel therapies.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Excitatory amino acids in epilepsy and potential novel therapies.
@ast
Excitatory amino acids in epilepsy and potential novel therapies.
@en
type
label
Excitatory amino acids in epilepsy and potential novel therapies.
@ast
Excitatory amino acids in epilepsy and potential novel therapies.
@en
prefLabel
Excitatory amino acids in epilepsy and potential novel therapies.
@ast
Excitatory amino acids in epilepsy and potential novel therapies.
@en
P1433
P1476
Excitatory amino acids in epilepsy and potential novel therapies.
@en
P2093
Meldrum BS
P304
P356
10.1016/0920-1211(92)90040-Z
P577
1992-07-01T00:00:00Z